Australian Cooperative Research Centre for Biomarker Translation

The Australian Cooperative Research Centre for Biomarker Translation (BT-CRC) was a collaborative research organization dedicated to the discovery, validation, and commercialization of clinical biomarkers. Established in 2007 with support from the Australian Government's CRC Program, the center focused on bridging the gap between laboratory research and the diagnostic market. Its primary therapeutic areas included oncology, specifically colorectal and prostate cancers, and various inflammatory conditions. By integrating proteomics and genomics with clinical validation, BT-CRC aimed to develop high-accuracy diagnostic and prognostic tools. The center successfully partnered with major industry players like Roche and Healthscope to facilitate the translation of its research into global healthcare products.